These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

123 related items for PubMed ID: 2902642

  • 1. Zuclopenthixol decanoate in the management of behavioural disorders in mentally handicapped patients.
    Izmeth MG, Khan SY, Kumarajeewa DI, Shivanathan S, Veall RM, Wiley YV.
    Pharmatherapeutica; 1988; 5(4):217-27. PubMed ID: 2902642
    [Abstract] [Full Text] [Related]

  • 2. A double-blind comparative trial of the decanoates of clopenthixol and fluphenazine in the treatment of chronic schizophrenic out-patients.
    Walker CA.
    Pharmatherapeutica; 1983; 3(5):289-93. PubMed ID: 6133287
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Long-term treatment of chronic schizophrenics with clopenthixol decanoate.
    Borsetti G, Rocco P, Spilimbergo PG, Giavedoni A, Frangiamone L, Beccaceci A, Judice A, Cisternino M, Volterra V.
    Pharmatherapeutica; 1984; 4(1):53-6. PubMed ID: 6150492
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Zuclopenthixol decanoate and haloperidol decanoate in chronic schizophrenia: a double-blind multicentre study.
    Wistedt B, Koskinen T, Thelander S, Nerdrum T, Pedersen V, Mølbjerg C.
    Acta Psychiatr Scand; 1991 Jul; 84(1):14-21. PubMed ID: 1681680
    [Abstract] [Full Text] [Related]

  • 13. A 5-year follow-up study of chronic schizophrenics treated with clopenthixol decanoate.
    Carney MW.
    Pharmatherapeutica; 1984 Jul; 4(1):57-63. PubMed ID: 6150493
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. [A new injectable delayed-action neuroleptic with sedative and antipsychotic action: cis-(Z)-clopenthixol decanoate. Clinical trials].
    Lambert PA, Chabannes JP.
    Encephale; 1984 Jul; 10(2):83-91. PubMed ID: 6381033
    [Abstract] [Full Text] [Related]

  • 16. A double-blind placebo-controlled discontinuation study of zuclopenthixol for the treatment of aggressive disruptive behaviours in adults with mental retardation - secondary parameter analyses.
    Hässler F, Glaser T, Pap AF, Beneke M, Diefenbacher A, Reis O, Zuclopenthixol Disruptive Behavior Study Group.
    Pharmacopsychiatry; 2008 Nov; 41(6):232-9. PubMed ID: 19067260
    [Abstract] [Full Text] [Related]

  • 17. Clinical and pharmacokinetic evaluation of zuclopenthixol acetate in Viscoleo.
    Balant LP, Balant-Gorgia AE, Eisele R, Reith B, Gex-Fabry M, Garrone G.
    Pharmacopsychiatry; 1989 Nov; 22(6):250-4. PubMed ID: 2575763
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.